What are the possible implications of Covid-19 on the biopharmaceutical and the wider pharmaceutical markets?
Steve Kent is currently Non-Executive Chairman at Phlexglobal, 4ways and Pharmaspectra, as well as Non-Executive Director at Imagen Therapeutics. During Steve’s time as an executive